Game On Mole is back this summer!
13 November 2020
The edgy Game On Mole campaign leverages the iconic Aussie catch-cry ‘game on, mole’, encouraging young Australians to check their skin for changes and then seek medical advice if they notice any changes.
It calls on Aussies to don a limited-edition ‘Game On Mole’ T-shirt and share selfies on social media tagged #gameonmole to generate life-saving conversations around sun safety and skin health.
With one Australian expected to be diagnosed with melanoma every half an hour this year, Olympian and melanoma survivor, Cate Campbell, is once again fronting the campaign.
‘I am living proof that early detection is vital to saving lives from melanoma. We need to be having discussions about sun-safety and checking your skin for changes, and I encourage all Aussies to buy a t-shirt, wear it proudly, and start those life-saving conversations.’
CEO of Melanoma Institute Australia, Matthew Browne, said the campaign uses Australian humour to relay a serious message.
‘We know Australians love a laugh almost as much as they love soaking up the sun. But melanoma is no laughing matter, with one Australian dying from the disease every five hours and it being the most common cancer impacting 15 to 39 year olds.
‘The strength of this campaign lies in its capacity to empower all Australians to be a part of the solution by wearing a t-shirt that begs the question ‘what is that about?’ It’s a great conversation starter about what is largely a preventable disease.’
This year’s campaign includes a range of new t-shirt designs giving people a variety of ways to spread the ‘Game On Mole’ message. T-shirt sales also help fund ongoing research by Melanoma Institute Australia into new treatments to save lives from melanoma.
For more information, please contact:
Jennifer Durante |Melanoma Institute Australia | 0412 798 990 | firstname.lastname@example.org
Can an individual’s risk factors for melanoma be used to tailor skin self-examinations and surveillance programs?
Prof Georgina Long has been appointed President-Elect Society for Melanoma Research (SMR).
The Australasian Melanoma Conference is bringing together some of the world's leading researchers and clinicians.
Best practice guidelines for melanoma care have gone digital with the first-ever online guidelines developed to adapt to the rapid change in clinical management.
Congratulations are in order for two of our talented researchers.
Professor Richard Scolyer will be sharing his expertise on melanoma pathology at the upcoming Australasian Melanoma Conference. Here he discusses what he'll be presenting on.
Researchers at MIA have established a High Risk Clinic to monitor people at very high risk of developing melanoma.
A generous donation has enabled a medical oncologist from Portugal to learn from the best in the world at MIA.
MIA is hosting a conference to bring together greats minds in melanoma research that will make a difference to the lives of melanoma patients
Meet Michelle, our Translational Research Officer whose role is to connect the clinics to the lab by ensuring patient blood and tissue samples are documented and carefully stored in our BioSpecimen Bank.
Dr James Wilmott says his Wildfire Award will help expand research into treatment options for people with mucosal melanoma, a rare but deadly form of skin cancer.
Following the recent hype around immunotherapies in cancer, CEO Carole Renouf shares the greatest story never told… resistance… and what MIA is doing to address it.
A/Prof Wargo discusses the research she will be presenting as a keynote speaker at the upcoming Australasian Melanoma Conference.
Dr James Wilmott has been awarded the Wildfire award at this year's Cancer Institute NSW's Premier Awards for Outstanding Cancer Research.
The community has responded generously to our recent appeal to fund a specialised nursing position in an exciting new clinical trial.
We have developed a unique clinical trial that will use existing drugs to target rare genes in melanoma patients.
Data presented at the recent ASCO Annual Meeting showcased advances in melanoma research, particularly long-term survival data.
We value your privacy and want you to be familiar with how we collect, use and disclose your information.
Melanoma Institute Australia has partnered with IBM Research in Australia to help further advance melanoma identification using cognitive technology.
CEO Carole Renouf chats to senior clinicians and researchers as part of our "4 Questions With..." short video series.